← Leaderboards
Nicholas J Dyson
Massachusetts General Hospital
$20,553,237
Attributed
$21,163,860
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$21,163,860 · 10
By mechanism
R01$17,659,388 · 7
U01$3,053,683 · 1
P30$450,789 · 1
P01$0 · 1
Top collaborators
- Anna Flora Farago2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Joseph Vincent Bonventre$46,605,730
- Dennis Brown$23,445,948
- Krishna P Reddy$8,351,137
- David Nelson Kennedy$22,953,236
- Uri Tzvi Eden$7,604,510
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsRetinoblastoma ProteinCell ProliferationCellsProteinsGenetic TranscriptionUnited StatesMolecularGenesBaseTumorTumor Suppressor ProteinsCell CyclePhenotypeRegulationMutantComplexMutationGeneticPropertyProliferatingAllelesNeoplastic CellEvent
Grant awards (60)
Using patient-derived models to understand drug responses in SCLC$599,095
U01 · FY2022 · CA · contact PI
Deciphering the code of RB phosphorylation$493,135
R01 · FY2022 · CA · contact PI
Using patient-derived models to understand drug responses in SCLC$613,419
U01 · FY2021 · CA · contact PI
Deciphering the code of RB phosphorylation$503,198
R01 · FY2021 · CA · contact PI
Using patient-derived models to understand drug responses in SCLC$619,923
U01 · FY2020 · CA · contact PI
Deciphering the code of RB phosphorylation$503,198
R01 · FY2020 · CA · contact PI
Using patient-derived models to understand drug responses in SCLC$601,323
U01 · FY2019 · CA · contact PI
The consequences of RB-loss$511,782
R01 · FY2019 · GM · contact PI
Deciphering the code of RB phosphorylation$488,101
R01 · FY2019 · CA · contact PI
Using patient-derived models to understand drug responses in SCLC$619,923
U01 · FY2018 · CA · contact PI
The consequences of RB-loss$511,782
R01 · FY2018 · GM · contact PI
Deciphering the code of RB phosphorylation$503,198
R01 · FY2018 · CA · contact PI
The consequences of RB-loss$511,782
R01 · FY2017 · GM · contact PI
The consequences of RB-loss$520,092
R01 · FY2016 · GM · contact PI
Dissection and manipulation of RB function$361,050
R01 · FY2016 · CA · contact PI
Cancer Genetics$92,650
P30 · FY2016 · CA · contact PI
Dissection and manipulation of RB function$361,050
R01 · FY2015 · CA · contact PI
The Origins of Chromosomal Instability in Human Tumor Cells$361,050
R01 · FY2015 · CA · contact PI
Condensin II/RBF$285,308
R01 · FY2015 · CA · contact PI
Cancer Genetics$92,684
P30 · FY2015 · CA · contact PI
Dissection and manipulation of RB function$350,219
R01 · FY2014 · CA · contact PI
The Origins of Chromosomal Instability in Human Tumor Cells$350,219
R01 · FY2014 · CA · contact PI
Condensin II/RBF$276,748
R01 · FY2014 · CA · contact PI
Cancer Genetics$87,809
P30 · FY2014 · CA · contact PI
The Origins of Chromosomal Instability in Human Tumor Cells$339,387
R01 · FY2013 · CA · contact PI
Dissection and manipulation of RB function$339,387
R01 · FY2013 · CA · contact PI
Condensin II/RBF$268,190
R01 · FY2013 · CA · contact PI
Cancer Genetics$84,981
P30 · FY2013 · CA · contact PI
The Origins of Chromosomal Instability in Human Tumor Cells$361,741
R01 · FY2012 · CA · contact PI
Dissection and manipulation of RB function$361,223
R01 · FY2012 · CA · contact PI
Condensin II/RBF$285,308
R01 · FY2012 · CA · contact PI
Cancer Genetics$92,665
P30 · FY2012 · CA · contact PI
The Origins of Chromosomal Instability in Human Tumor Cells$367,275
R01 · FY2011 · CA · contact PI
The Enhancement and Suppression of E2F-Dependent Apoptosis$326,138
R01 · FY2011 · GM · contact PI
Condensin II/RBF$285,308
R01 · FY2011 · CA · contact PI
E2F-dependent cell proliferation$398,475
R01 · FY2010 · GM · contact PI
The Enhancement and Suppression of E2F-Dependent Apoptosis$317,824
R01 · FY2010 · GM · contact PI
E2F-dependent cell proliferation$402,500
R01 · FY2009 · GM · contact PI
The Enhancement and Suppression of E2F-Dependent Apoptosis$320,027
R01 · FY2009 · GM · contact PI
Mutagenesis of the pRB pocket$282,084
R01 · FY2009 · CA · contact PI
E2F-dependent cell proliferation$402,500
R01 · FY2008 · GM · contact PI
The Enhancement and Suppression of E2F-Dependent Apoptosis$330,097
R01 · FY2008 · GM · contact PI
Mutagenesis of the pRB pocket$282,084
R01 · FY2008 · CA · contact PI
E2F-dependent cell proliferation$402,500
R01 · FY2007 · GM · contact PI
Mutagenesis of the pRB pocket$282,084
R01 · FY2007 · CA · contact PI
The E2F/RBF network$380,103
R01 · FY2006 · GM · contact PI
Mutagenesis of the pRB pocket$290,509
R01 · FY2006 · CA · contact PI
The E2F/RBF network$389,250
R01 · FY2005 · GM
Mutagenesis of the pRB pocket$297,500
R01 · FY2005 · CA
The E2F/RBF network$389,250
R01 · FY2004 · GM
MUTAGENESIS OF THE PRB POCKET DOMAIN$255,267
R01 · FY2004 · CA
The E2F/RBF network$389,250
R01 · FY2003 · GM
MUTAGENESIS OF THE PRB POCKET DOMAIN$255,267
R01 · FY2003 · CA
FUNCTION OF THE E2F TRANSCRIPTION FACTOR$341,614
R01 · FY2002 · GM
MUTAGENESIS OF THE PRB POCKET DOMAIN$255,267
R01 · FY2002 · CA
Identification of novel modifiers of E2F/RB function$0
P01 · FY2002 · CA
FUNCTION OF THE E2F TRANSCRIPTION FACTOR$334,353
R01 · FY2001 · GM
MUTAGENESIS OF THE PRB POCKET DOMAIN$255,267
R01 · FY2001 · CA
FUNCTION OF THE E2F TRANSCRIPTION FACTOR$325,180
R01 · FY2000 · GM
MUTAGENESIS OF THE PRB POCKET DOMAIN$255,267
R01 · FY2000 · CA